CHEMOCENTRYX INC stock forecast: up to 19.26 USD CCXI stock price prognosis


Forecast for Fri 20 Aug 2021 price 27.33

CHEMOCENTRYX INC stock price forecast for further price development up to 47.45% (time horizon: 1 day) and price target of 19.26 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) CHEMOCENTRYX INC share price prediction for 2021-08-20 with daily closed price projections

Key Facts

Symbol CCXI 

ISIN US16383L1061 

CUSIP 16383L106

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

News sentiment (0.14)

Finance numbers

Revenue 33,809,000.0

Earnings per share -1.10

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.


We plan to initiate a Phase I clinical trial of CCX559 in the first half of 2021. The placebo-controlled treatment period was 26 weeks (182 days). The disease originates from inflammation and occlusion of the hair follicle. Serious TEAEs were observed in 2.3% of placebo patients vs. 1.5% on avacopan. In October 2020, we entered into a manufacturing and supply agreement with Vifor. We plan to advance CCX559 into a Phase I clinical trial in the first half of 2021. We believe that these are potential therapeutic opportunities for a CCR6 inhibitor. The address of that website is The following list summarizes some, but not all, of these risks. We may also face delays in the development and commercialization of our drug candidates. 8226; We may be adversely affected by the economic environment. &# Further, chemokine receptors and chemoattractant receptors are a novel class of targets. Some or all of our drug candidates may prove to be unsafe for human use. We cannot assure you that any of our patent applications will result in issued patents. For example, in March 2010, the Affordable Care Act was signed into law. These changes will lead to additional costs and increase our overall risk. As of December 31, 2020, we had 69,452,466 shares of common stock outstanding. We have broad discretion in the use of our cash and may not use it effectively.

Summerized Form 10-K with GPT-2
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 44.53/100
    • Good financial position.
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.
    • Stock price is above book price value.

Institutional ownership list is based on filling form information

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Allianz Variable Insurance Products Trust 2020-09-30 2202 Long
Bridge Builder Trust 2020-09-30 23852 Long
RUSSELL INVESTMENT CO 2020-10-31 -758 Short
RUSSELL INVESTMENT CO 2020-10-31 15494 Long

Insider trading for CHEMOCENTRYX INC

CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1422995 Cappel Markus J. 2021-03-01 SALE Accept Accept Accept Accept
1757924 Vifor Fresenius Medical Care Renal Pharma Ltd. 2020-07-31 SALE Accept Reject Reject Reject
1423084 Schall Thomas J. 2020-12-14 SALE Reject Reject Accept Accept
1648283 Edwards Thomas A. 2021-03-02 SALE Accept Accept Accept Accept
1733642 Kwan Pui San 2021-03-01 SALE Accept Accept Accept Accept

CHEMOCENTRYX INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

On-Balance Volume information for CHEMOCENTRYX INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for CHEMOCENTRYX INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for CHEMOCENTRYX INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for CHEMOCENTRYX INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for CHEMOCENTRYX INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for CHEMOCENTRYX INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for CHEMOCENTRYX INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

52W High 52W Low Market Cap

Similar shares



Figure below show the stock predictions.
Date Closing price Prediction was updated
2021-07-19 19.26 2021-06-25 01:24
2021-07-21 20.01 2021-06-25 01:24
2021-07-20 19.63 2021-06-25 01:24
2021-07-07 15.77 2021-06-25 01:46
2021-07-02 14.96 2021-06-25 01:46
2021-07-05 15.25 2021-06-25 01:46
2021-07-06 15.57 2021-06-25 01:46
2021-06-30 14.29 2021-06-25 01:46
2021-06-25 13.35 2021-06-25 01:46
2021-06-28 13.62 2021-06-25 01:46
2021-06-29 13.95 2021-06-25 01:46
2021-07-22 20.40 2021-06-25 01:24
2021-07-01 14.67 2021-06-25 01:46
2021-07-14 18.20 2021-06-25 01:24
2021-07-26 21.17 2021-06-25 01:24
2021-07-27 21.54 2021-06-25 01:24
2021-07-28 21.90 2021-06-25 01:24
2021-07-08 16.03 2021-06-25 01:46
2021-07-09 17.20 2021-06-25 01:24
2021-07-12 17.55 2021-06-25 01:24
2021-07-13 17.87 2021-06-25 01:24
2021-07-15 18.55 2021-06-25 01:24
2021-07-16 18.89 2021-06-25 01:24
2021-07-23 20.78 2021-06-25 01:24
2021-07-29 22.26 2021-06-25 01:24
2021-07-30 22.60 2021-06-25 01:24
2021-08-02 22.94 2021-06-25 01:24
2021-08-03 23.28 2021-06-25 01:24
2021-08-04 23.61 2021-06-25 01:24
2021-08-05 23.94 2021-06-25 01:24
2021-08-06 24.26 2021-06-25 01:24
2021-08-09 24.58 2021-06-25 01:24
2021-08-10 24.91 2021-06-25 01:24
2021-08-11 25.22 2021-06-25 01:24
2021-08-12 25.54 2021-06-25 01:24
2021-08-13 25.85 2021-06-25 01:24
2021-08-16 26.15 2021-06-25 01:24
2021-08-17 26.46 2021-06-25 01:24
2021-08-18 26.75 2021-06-25 01:24
2021-08-19 27.05 2021-06-25 01:24
2021-08-20 27.33 2021-06-25 01:24